Cervical Cancer Treatment in Turkey

Cervical Cancer Treatment in Turkey

Turkey has become one of the leading destinations for international patients seeking high-quality cancer care at reasonable prices. Cervical cancer treatment in Turkey typically costs between $4,000 and $20,000 depending on the stage, treatment protocol, and hospital, while the same procedures can easily exceed $50,000 to $100,000 in the United States and $30,000 to $70,000 in the United Kingdom. Beyond the cost gap, patients in many Western countries face long waiting lists that can stretch for weeks or even months, making it nearly impossible to begin treatment promptly. In Turkey, patients can often secure an appointment within days, receive a full diagnosis, and start their treatment plan without delay. This combination of affordability, speed, and clinical excellence is why thousands of patients from Europe, the Middle East, and beyond are choosing Turkey for cervical cancer care each year.

Cost of Cervical Cancer Treatment in Turkey (2026)

One of the biggest advantages of receiving cervical cancer treatment in Turkey is the significant cost savings compared to Western countries. Turkish hospitals offer JCI-accredited oncology services at a fraction of the price, without compromising on technology or expertise. Below is a general comparison of common cervical cancer procedures:

These prices are approximate and may vary depending on the hospital, the complexity of the case, and the specific treatment protocol. Many Turkish hospitals also offer all-inclusive packages that cover diagnostics, treatment, accommodation, and aftercare, making it even easier to plan your medical journey.

What Is Cervical Cancer?

Cervical cancer develops in the cells lining the cervix, which is the lower, narrow part of the uterus that connects to the vagina. It typically grows slowly and begins as precancerous changes known as cervical dysplasia. These abnormal cells, if left untreated, can eventually become cancerous over a period of years. The Human Papillomavirus (HPV) is responsible for the vast majority of cervical cancer cases, making it one of the most preventable forms of cancer when caught early through regular screening.

Cervical cancer is the fourth most common cancer among women globally, with approximately 660,000 new cases diagnosed each year according to the World Health Organization. Despite these numbers, early detection through Pap smears and HPV testing has dramatically improved survival rates, particularly in countries with robust screening programs. For patients diagnosed at later stages or those seeking more affordable treatment options, cancer treatment in Turkey has emerged as a viable and trusted alternative to care in Western Europe or North America.

Symptoms of Cervical Cancer

In its earliest stages, cervical cancer rarely causes any noticeable symptoms, which is why routine screening is so critical. As the disease progresses, the following symptoms may appear:

• Abnormal vaginal bleeding, such as bleeding between periods, after sexual intercourse, or after menopause
• Unusual vaginal discharge that may be watery, bloody, or have a foul odor
• Pelvic pain or pain during sexual intercourse (dyspareunia)
• Heavier or longer menstrual periods than usual
• Unexplained weight loss and persistent fatigue
• Leg swelling or pain, which may indicate advanced disease
• Pain in the lower back or abdomen
• Difficulty urinating or blood in the urine in advanced stages

If you experience any of these symptoms, it is important to consult a gynecologist promptly. Early diagnosis significantly improves the chances of successful treatment and recovery.

Causes and Risk Factors of Cervical Cancer

Understanding the causes and risk factors of cervical cancer can help women take preventive measures and seek timely screening. The primary risk factors include:

• Human Papillomavirus (HPV) infection: HPV is the single most significant risk factor. High-risk strains such as HPV-16 and HPV-18 are responsible for approximately 70% of all cervical cancer cases.
• Weakened immune system: Conditions like HIV/AIDS or long-term use of immunosuppressive medications reduce the body's ability to fight off HPV infections.
• Smoking: Tobacco use doubles the risk of cervical cancer. Chemicals in cigarette smoke damage cervical cell DNA and weaken the immune response in the cervix.
• Long-term use of oral contraceptives: Using birth control pills for five or more years has been associated with a slightly increased risk.
• Multiple full-term pregnancies: Women who have had three or more full-term pregnancies may have an elevated risk due to hormonal and immune changes during pregnancy.
• Early sexual activity and multiple sexual partners: These factors increase the likelihood of HPV exposure.
• Family history: Having a first-degree relative (mother or sister) who had cervical cancer increases individual risk.
• Lack of regular screening: Women who do not undergo routine Pap smears and HPV tests are more likely to be diagnosed at a later stage.

For patients exploring international options beyond cervical cancer, our comprehensive guide on the best countries and hospitals for cancer treatment provides valuable insight into top-ranked oncology centers worldwide.

Types of Cervical Cancer

Cervical cancer is classified based on the type of cell where it originates. Identifying the specific type is essential for determining the most effective treatment approach.

Squamous Cell Carcinoma

Squamous cell carcinoma is the most common type, accounting for approximately 70-80% of all cervical cancer cases. It develops in the thin, flat squamous cells that line the outer surface of the cervix (the ectocervix). This type is strongly linked to persistent HPV infection. It typically begins in the transformation zone, where the ectocervix meets the endocervix, and is usually detectable through Pap smear screening before it becomes invasive.

Adenocarcinoma

Adenocarcinoma makes up about 20-25% of cervical cancers and originates in the glandular cells of the endocervical canal. This type can be more challenging to detect through standard Pap tests because the abnormal cells develop higher up in the cervical canal. Adenocarcinoma has become relatively more common in recent decades and is also associated with HPV infection, particularly HPV-18. In some rare cases, mixed carcinomas (adenosquamous carcinomas) containing both squamous and glandular cancer cells may also occur.

How Cervical Cancer Is Diagnosed in Turkey

Turkish hospitals follow internationally recognized diagnostic protocols to ensure accurate staging and treatment planning. The diagnostic process for cervical cancer in Turkey typically involves several steps:

• Pap Smear (Cervical Cytology): This is the primary screening test that collects cells from the cervix to check for abnormalities. It can detect precancerous changes years before they develop into cancer.
• HPV DNA Testing: This test identifies the presence of high-risk HPV strains. It is often performed alongside or as a follow-up to the Pap smear to provide a more comprehensive screening result.
• Colposcopy and Biopsy: If abnormal results are found, a colposcope is used to magnify and examine the cervix closely. Tissue samples (biopsies) are taken from suspicious areas and sent to pathology for definitive diagnosis.
• Imaging Studies: MRI, CT scans, and PET-CT scans are used to determine the extent of the disease and whether it has spread to nearby lymph nodes or distant organs. PET-CT is particularly useful for staging advanced cervical cancer.
• FIGO Staging: Once all diagnostic information is gathered, the cancer is staged using the FIGO (International Federation of Gynecology and Obstetrics) system. This staging guides the entire treatment plan and helps determine the prognosis.

Stages of Cervical Cancer

Cervical cancer is staged from I to IV based on the size of the tumor and how far it has spread. Understanding the stage at diagnosis is critical because it directly determines the treatment options available.

Who Is a Good Candidate for Cervical Cancer Treatment in Turkey?

Turkey welcomes patients from all over the world for cancer care. You may be an ideal candidate for cervical cancer treatment in Turkey if you:

• Have been diagnosed with cervical cancer at any stage and are seeking affordable, high-quality treatment
• Are facing long waiting times for surgery, radiation, or chemotherapy in your home country
• Want access to minimally invasive surgical options, including robotic-assisted and laparoscopic procedures
• Are looking for a second opinion from experienced gynecologic oncologists
• Need fertility-sparing treatment and want to explore trachelectomy or conservative surgical options
• Require advanced radiation therapy techniques such as IMRT or brachytherapy
• Are seeking a comprehensive, multidisciplinary approach to your cancer care
• Want all-inclusive medical travel support including accommodation, translation, and airport transfers

Types of Cervical Cancer Treatment in Turkey

Turkish oncology centers offer a full spectrum of treatment modalities for cervical cancer, tailored to the individual patient based on cancer stage, overall health, and personal preferences.

Surgery (Hysterectomy)

Surgery remains the primary treatment for early-stage cervical cancer. The specific type of surgery depends on the extent of the disease. A simple hysterectomy removes the uterus and cervix, while a radical hysterectomy also removes the parametrial tissue, the upper portion of the vagina, and pelvic lymph nodes. Turkish hospitals commonly perform these procedures using minimally invasive techniques, including laparoscopic and robotic-assisted surgery with the da Vinci Surgical System. These approaches result in smaller incisions, reduced blood loss, less post-operative pain, and faster recovery times compared to traditional open surgery.

Radiation Therapy

Radiation therapy uses high-energy beams to destroy cancer cells and is a cornerstone of cervical cancer treatment, especially for locally advanced disease (stages IIB-IVA). Turkish hospitals employ state-of-the-art equipment including Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and TrueBeam linear accelerators. Brachytherapy, where a radioactive source is placed directly inside or next to the tumor, is frequently used in combination with external beam radiation for optimal results. Both high-dose rate (HDR) and low-dose rate (LDR) brachytherapy options are available.

Chemotherapy

Chemotherapy is often used in combination with radiation therapy (concurrent chemoradiation) as the standard of care for locally advanced cervical cancer. The most commonly used regimen is cisplatin-based chemotherapy administered weekly during radiation. For metastatic or recurrent cervical cancer, combination regimens such as cisplatin or carboplatin with paclitaxel are used, frequently alongside bevacizumab (a targeted therapy). Chemotherapy may also be given as neoadjuvant therapy before surgery or as adjuvant therapy afterward to reduce the risk of recurrence.

Patients dealing with advanced-stage cancers may also benefit from reading our guide to stage 4 breast cancer treatment options abroad, which covers treatment planning and international care pathways for complex oncology cases.

Targeted Therapy and Immunotherapy

Targeted therapy and immunotherapy have revolutionized the treatment of advanced and recurrent cervical cancer. Bevacizumab (Avastin) is a targeted agent that inhibits the formation of new blood vessels that feed the tumor, and it is commonly added to chemotherapy regimens for metastatic disease. Pembrolizumab (Keytruda), a checkpoint inhibitor, has been approved for cervical cancer patients whose tumors express PD-L1 or have high microsatellite instability (MSI-H). Tisotumab vedotin (Tivdak), an antibody-drug conjugate, is another option for recurrent or metastatic cervical cancer. Many Turkish oncology centers also participate in international clinical trials, offering patients access to experimental treatments.

Fertility-Sparing Treatment Options

For younger women diagnosed with early-stage cervical cancer who wish to preserve their fertility, Turkish hospitals offer conservative surgical options. Radical trachelectomy removes the cervix and surrounding tissue while preserving the uterus, allowing future pregnancies. Cone biopsy (conization) may be sufficient for very early-stage disease (stage IA1). These procedures are performed by highly experienced gynecologic oncologists and are followed by close surveillance to monitor for recurrence.

How Cervical Cancer Treatment Is Performed

The treatment process for cervical cancer in Turkey typically follows a structured, patient-centered approach. Upon arrival, patients undergo a thorough initial evaluation that includes a physical examination, imaging studies (MRI, PET-CT), blood work, and a review of any previous pathology reports. A multidisciplinary tumor board consisting of gynecologic oncologists, radiation oncologists, medical oncologists, pathologists, and radiologists reviews each case to formulate a personalized treatment plan.

For surgical patients, the procedure is typically scheduled within a few days of the initial consultation. Minimally invasive approaches are preferred whenever clinically appropriate. Patients receiving radiation therapy usually begin treatment within one to two weeks, with sessions conducted five days a week over a period of five to six weeks. Chemotherapy, when given concurrently, is administered once weekly. Throughout the treatment process, patients have regular follow-up appointments to monitor response and manage any side effects.

Recovery After Cervical Cancer Treatment

Recovery timelines vary depending on the type of treatment received. After minimally invasive surgery, most patients can return to light activities within two to three weeks and resume normal activities within four to six weeks. Open surgical procedures may require a longer recovery period of six to eight weeks. Radiation and chemotherapy patients may experience gradual improvement in side effects over several weeks to months following the completion of treatment.

Follow-up care is essential after cervical cancer treatment. Patients are typically advised to have regular check-ups every three to four months during the first two years, then every six months for the next three years. These visits include pelvic examinations, Pap smears, and imaging studies as needed. Turkish hospitals provide detailed discharge instructions and many offer remote follow-up consultations for international patients who have returned home.

Risks and Side Effects of Treatment

As with any cancer treatment, cervical cancer therapies carry potential risks and side effects. Being informed about these helps patients prepare and manage expectations:

• Surgery: Possible risks include bleeding, infection, blood clots, lymphedema (leg swelling), bladder or bowel dysfunction, and early menopause if the ovaries are removed.
• Radiation therapy: Common side effects include fatigue, skin irritation in the treatment area, diarrhea, nausea, vaginal narrowing (stenosis), and bladder irritation. Long-term effects may include vaginal dryness and, rarely, bowel or bladder complications.
• Chemotherapy: Typical side effects include nausea and vomiting, hair loss, fatigue, increased risk of infection due to low white blood cell counts, anemia, and peripheral neuropathy (numbness or tingling in hands and feet).
• Targeted therapy and immunotherapy: Bevacizumab may cause high blood pressure, bleeding, or blood clots. Immunotherapy drugs can trigger immune-related side effects affecting the skin, liver, lungs, or endocrine system.

Your medical team in Turkey will closely monitor you throughout treatment and provide supportive care medications to help manage these side effects effectively.

Success Rates of Cervical Cancer Treatment

The success of cervical cancer treatment depends significantly on the stage at diagnosis. According to global oncology data, the five-year survival rates are approximately:

• Stage I: 80-93% five-year survival rate. At this stage, the cancer is confined to the cervix and is highly treatable with surgery alone or surgery combined with radiation.
• Stage II: 58-63% five-year survival rate. Concurrent chemoradiation is the standard treatment and yields strong outcomes.
• Stage III: 32-35% five-year survival rate. Treatment typically involves aggressive chemoradiation with brachytherapy.
• Stage IV: 15-16% five-year survival rate. While more challenging, newer immunotherapy and targeted therapy agents are improving outcomes for advanced-stage patients.

Turkish hospitals report outcomes that are consistent with or comparable to leading oncology centers in Europe and the United States. The key to successful treatment remains early detection and prompt initiation of appropriate therapy.

For a broader overview of medical expenses across different specialties, visit our detailed guide on treatment costs in Turkey.

Why Choose Turkey for Cervical Cancer Treatment?

Turkey has positioned itself as a global hub for medical tourism, and oncology care is one of its strongest areas. There are several compelling reasons why patients choose Turkey for their cervical cancer treatment:

Advanced Oncology Hospitals

Turkey is home to over 50 JCI-accredited hospitals, many of which have dedicated oncology departments equipped with the latest technology. These facilities offer linear accelerators (TrueBeam, Elekta Versa HD), CyberKnife radiosurgery systems, PET-CT scanners, and robotic surgery platforms. The infrastructure in leading Turkish hospitals rivals that of top cancer centers in the United States, Germany, and the United Kingdom.

Experienced Gynecologic Oncologists

Turkish gynecologic oncologists are often trained at prestigious international institutions and bring decades of experience in treating cervical cancer. Many have performed hundreds of radical hysterectomies, trachelectomies, and complex pelvic surgeries. They stay current with the latest clinical guidelines from ESMO, NCCN, and FIGO, ensuring that patients receive evidence-based care.

Multidisciplinary Cancer Care

One of the hallmarks of cervical cancer care in Turkey is the multidisciplinary tumor board approach. Each patient's case is reviewed by a panel of specialists who collaborate to create an individualized treatment plan. This team-based approach has been shown to improve treatment outcomes and patient satisfaction across global oncology literature.

Affordable Treatment Options

As outlined in the cost comparison above, cervical cancer treatment in Turkey is available at a fraction of the cost charged in Western countries. This affordability does not come at the expense of quality. Turkey's lower cost of living, government healthcare incentives, and competitive hospital market all contribute to making world-class cancer care accessible to a wider range of patients.

International Patient Services

Major Turkish hospitals have dedicated international patient departments that handle everything from initial inquiry to post-treatment follow-up. Services typically include airport transfers, hotel or hospital accommodation arrangements, multilingual patient coordinators, translation services during consultations and procedures, visa invitation letters, and assistance with medical records and insurance documentation.

Best Hospitals for Cervical Cancer Treatment in Turkey

Turkey is home to numerous world-class hospitals with specialized oncology programs. Below are some of the top institutions where international patients receive cervical cancer care in Turkey, along with what makes each one stand out.

American Hospital Istanbul

Founded in 1920, American Hospital is one of Turkey's longest-established private healthcare institutions. Its Oncology Center houses a dedicated gynecologic oncology unit where specialists perform radical hysterectomies and fertility-sparing trachelectomies using the da Vinci Xi robotic surgery system. The hospital holds JCI accreditation and operates an in-house PET-CT unit, advanced MRI suites, and a TrueBeam linear accelerator for precision radiation therapy. American Hospital's tumor board meets weekly to review complex cervical cancer cases and tailor multidisciplinary treatment plans.

Koc University Hospital

Located on Istanbul's European side, Koc University Hospital is an academic medical center that combines clinical care with active oncology research. Its Gynecologic Oncology Clinic is led by professors who hold dual appointments in both clinical practice and university research programs. The hospital actively participates in international clinical trials for checkpoint inhibitors and antibody-drug conjugates in cervical cancer, giving patients access to emerging therapies not widely available elsewhere. Koc University Hospital is also equipped with an Elekta Versa HD linear accelerator and a fully integrated brachytherapy suite for HDR intracavitary treatment.

Optimed Health Group

Optimed Health Group focuses on providing personalized oncology care at competitive pricing, making it particularly attractive for medical tourism patients. Its gynecologic oncology team works closely with radiation oncologists and medical oncologists under one roof, streamlining the treatment process. Optimed is known for offering transparent, all-inclusive treatment packages that cover diagnostics, surgery, chemotherapy, hospital stays, and post-treatment follow-up in a single quoted price with no hidden costs.

Medipol Mega University Hospital

With over 470 beds and a campus spanning more than 200,000 square meters, Medipol Mega is one of the largest private university hospitals in Europe. Its Oncology Center operates three linear accelerators, a dedicated brachytherapy unit with HDR afterloader technology, and a CyberKnife M6 system for stereotactic radiosurgery. Medipol's gynecologic oncology department performs laparoscopic and robotic-assisted radical hysterectomies as well as pelvic and para-aortic lymphadenectomies. The hospital's nuclear medicine department provides Ga-68 PSMA and F-18 FDG PET-CT imaging for precise cancer staging.

Acibadem Healthcare Group

Acibadem operates over 20 hospitals across Turkey and holds JCI accreditation at multiple locations. Its Cancer Center at Acibadem Maslak Hospital features the Novalis Tx platform for image-guided radiosurgery and a comprehensive chemotherapy infusion center. Acibadem's gynecologic oncologists specialize in nerve-sparing radical hysterectomy techniques and sentinel lymph node mapping for cervical cancer, reducing unnecessary lymph node dissection and lowering the risk of post-surgical lymphedema. The group also maintains a centralized pathology laboratory with molecular diagnostics capabilities, including PD-L1 and MSI testing for immunotherapy eligibility.

Medical Park Hospitals

Operating 28 hospitals across Turkey, Medical Park provides widespread access to oncology services in multiple cities including Istanbul, Ankara, Antalya, and Izmir. Its flagship hospital in Istanbul Fatih houses a robotic surgery center and a radiation oncology department equipped with Varian Halcyon and TrueBeam systems. Medical Park's cervical cancer program includes concurrent chemoradiation protocols, IMRT, and 3D conformal brachytherapy, managed by a dedicated team of radiation oncologists with subspecialty training in gynecologic malignancies.

Liv Hospital

Liv Hospital Ulus in Istanbul was designed from the ground up as a technology-forward facility and has consistently been recognized among Turkey's top private hospitals. Its Oncology Clinic offers a full range of cervical cancer treatments, from minimally invasive laparoscopic surgery to advanced chemoradiation. Liv Hospital distinguishes itself with its Robotic Surgery Center, where gynecologic oncologists perform complex pelvic procedures with high precision. The hospital also provides a comfortable patient experience with private suites, multilingual nursing staff, and an in-house international patient department.

Memorial Hospital

JCI-accredited since 2002, Memorial Hospitals Group operates locations in Sisli, Atasehir, Bahcelievler (Istanbul), and Ankara. Memorial's Radiation Oncology Department uses TrueBeam STx and Elekta Versa HD accelerators for IMRT, IGRT, and stereotactic body radiation therapy. Its gynecologic oncology team is led by specialists who have performed over 900 radical pelvic procedures and routinely offer concurrent chemoradiation packages priced between $15,000 and $20,000, covering 20 radiation sessions, weekly chemotherapy, brachytherapy, and full diagnostics. Memorial also provides all-inclusive international patient packages with accommodation and transfer support.

Medicana Healthcare Group

Medicana operates 12 hospitals across Turkey and offers dedicated oncology services at its larger branches in Istanbul, Ankara, and Sivas. Its cervical cancer program includes conventional and laparoscopic surgical options, cisplatin-based chemoradiation, and outpatient chemotherapy infusion services. Medicana is known for its competitive pricing structure and responsive international patient coordination team, offering multilingual case managers who assist with treatment planning, appointment scheduling, and travel logistics.

Florence Nightingale Hospitals

One of Istanbul's most established hospital groups, Florence Nightingale has been operating since 1989 and manages multiple campuses including its flagship facility in Sisli and a newer campus in Gayrettepe. The group's oncology department provides comprehensive cervical cancer treatment including radical surgery, IMRT-based radiation therapy, and systemic chemotherapy. Florence Nightingale's pathology department offers rapid-turnaround biopsy results and advanced immunohistochemistry panels for accurate tumor characterization. The hospital group also runs an active palliative care and supportive oncology program for patients with advanced-stage disease.

How A-Medical Can Help?

Navigating cancer treatment abroad can feel overwhelming, especially when you are already dealing with the stress of a diagnosis. That is exactly where A-Medical steps in. As a trusted medical tourism facilitator, A-Medical connects international patients with the best oncology hospitals and gynecologic oncologists in Turkey, ensuring a seamless treatment experience from start to finish.

When you choose A-Medical, you benefit from:

• No waiting lists: We schedule your consultation and treatment within days, not weeks or months.
• Fast appointment booking: Our team coordinates directly with top Turkish hospitals to secure priority appointments.
• Best doctor and hospital matching: Based on your diagnosis, medical history, and treatment needs, we match you with the most suitable gynecologic oncologist and hospital.
• Accommodation support: We help arrange comfortable hotel or apartment stays near your treatment facility.
• Professional interpreter services: Multilingual interpreters accompany you to all medical appointments, ensuring clear communication with your medical team.
• Airport and local transfers: From the moment you land in Turkey until you depart, all ground transportation is taken care of.
• Most affordable treatment packages: We negotiate competitive pricing with our partner hospitals and present transparent cost breakdowns with no hidden fees.
• End-to-end care coordination: From obtaining your medical records and visa support to post-treatment follow-up, A-Medical manages every detail of your medical journey.

Ready to explore your treatment options? Contact A-Medical today for a free consultation and personalized treatment plan. Our medical advisors are here to guide you through every step of your cervical cancer treatment journey in Turkey.

If this is your first time considering treatment abroad, our guide on how medical travel to Turkey works walks you through the entire process step by step.

Conclusion

Cervical cancer treatment in Turkey combines clinical excellence, cutting-edge technology, and remarkable affordability, making it one of the top destinations for oncology patients worldwide. Whether you need surgery, radiation therapy, chemotherapy, or advanced immunotherapy, Turkish hospitals offer comprehensive care delivered by experienced specialists in modern, JCI-accredited facilities. With significantly lower costs than the US, UK, and much of Europe, zero waiting lists, and dedicated support for international patients, Turkey provides a compelling option for women facing a cervical cancer diagnosis.

A-Medical is your trusted partner throughout this journey. Get in touch with us today to receive a free, no-obligation quote and let us help you access the best cervical cancer care Turkey has to offer.

Frequently Asked Questions

How much does cervical cancer treatment cost in Turkey?

The cost of cervical cancer treatment in Turkey ranges from approximately $4,000 to $20,000, depending on the stage of the cancer and the specific treatments required. This includes surgery, radiation therapy, chemotherapy, and diagnostics. These prices are significantly lower than comparable treatments in the US ($50,000-$100,000) and the UK ($30,000-$70,000).

Is cervical cancer treatment in Turkey safe for international patients?

Yes, cervical cancer treatment in Turkey is safe and meets international standards. Over 50 Turkish hospitals hold JCI accreditation, which is the gold standard for healthcare quality worldwide. Gynecologic oncologists in Turkey are highly trained, many with international fellowships, and hospitals use the same advanced equipment and treatment protocols as leading cancer centers in Europe and North America.

What is the success rate of cervical cancer treatment in Turkey?

The success rate depends on the stage at diagnosis. Early-stage cervical cancer (Stage I) has a five-year survival rate of 80-93%. Turkish oncology centers achieve outcomes comparable to top hospitals in the US and Europe, supported by multidisciplinary tumor boards and access to the latest treatment technologies.

How long do I need to stay in Turkey for cervical cancer treatment?

The length of stay varies by treatment type. Surgical patients typically need 7-14 days in Turkey, while patients receiving concurrent chemoradiation may need to stay for 5-7 weeks to complete the full treatment course. A-Medical helps arrange comfortable accommodation for the entire duration of your stay.

Can I preserve my fertility during cervical cancer treatment in Turkey?

Yes, fertility-sparing options are available for eligible patients with early-stage cervical cancer. Radical trachelectomy removes the cervix while preserving the uterus, allowing future pregnancies. Conization may also be an option for very early-stage disease. Your gynecologic oncologist will assess whether these conservative approaches are appropriate for your specific case.

Does A-Medical provide support for international patients traveling to Turkey for cancer treatment?

Absolutely. A-Medical provides comprehensive support including fast appointment scheduling, hospital and doctor matching, accommodation arrangements, professional interpreter services, airport transfers, and ongoing care coordination. Our goal is to make your medical journey as smooth and stress-free as possible so you can focus entirely on your recovery.